Epacadostat in Combination With Pembrolizumab and Azacitidine in Subjects With Metastatic Colorectal Cancer

Stopped Study will not be conducted due to changes related to the investigational agent.

Conditions

• Metastatic Colorectal Cancer

Interventions

• DRUG: Epacadostat (INCB024360) in Combination with Pembrolizumab (MK-3475) and Azacitidine (VIDAZA)

Sponsor

James J Lee

Collaborators

• [object Object]
• [object Object]